Pharmacists in Janesville, WI Accepting Medicare
66 Pharmacists found. Showing 61 - 66
 Mrs. Hanlie De Vries, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-741-9681 Fax: 608-741-6977 |
Michelle T Arend, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2519 Kettering St, Janesville, WI 53546 Phone: 608-754-0007 |
 Dr. Seung-ri Lee, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Milton Ave, Janesville, WI 53545 Phone: 608-756-0614 |
Kristin L Peterson, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 580 N Washington St, Suite 300, Janesville, WI 53548 Phone: 608-755-3599 Fax: 608-755-3553 |
Jamie Murray, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1717 Milton Ave, Janesville, WI 53545 Phone: 608-754-2278 |
Mr. Jesse Meserole, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1717 Milton Ave, Janesville, WI 53545 Phone: 608-754-2278 |
News Archive
Medline to distribute anesthesia medical devices and single-use products in U.S. and Canada
Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of healthcare supplies, announced today the signing of an exclusive agreement with te me na SAS to distribute Polymedic® brand regional anesthesia medical devices and single-use products in the U.S. and Canada.
PolyMedix receives patent protection for computational methods in the design of amphiphilic polymers
PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, "Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers."
GlaxoSmithKline's CERVARIX recommended by CDC for protection against cervical cancer
GlaxoSmithKline announced today that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) recommended that CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] be given to girls and young women to protect against cervical pre-cancers and cervical cancer caused by oncogenic HPV 16 and 18.
Lack of signaling protein CXCR4 may halt cancer development
Zebrafish-human communication shows that cancer cells lacking a signaling protein are less able to develop aggressive metastatic properties.
› Verified 2 days ago
Counselors
Dentists
Pharmacists
Occupational Therapists
Clinical Social Workers
Psychologists